Dr. Mark Holterman is currently the Chief of Pediatric Surgery at the University of Illinois. Dr. Holterman has held this position for approximately six years. Previously, Dr. Mark Holterman was an Associate Professor at the University of Illinois at Chicago.
Dr. Holterman has enjoyed working with children throughout his entire career. Earlier in his career, Dr. Holterman was on staff at Children’s Hospital in Oak Lawn Illinois. Dr. Holterman is an expert within the field of Pediatric medicine and surgery. Read more about Dr. Mark Holterman at Health Grove.
Dr. Mark Holterman has some impressive educational credentials. He graduated from Yale University with a degree in Biology. In addition, he attended the University of Virginia where he received his MD as well as his PHD. Dr. Holterman graduated from Medical School with honors.
Dr. Holterman completed his fellowship at the University of Washington which is located in Seattle. Dr. Holterman concentrated on pediatric health issues concerning breathing and airway obstruction as well as abdominal abnormalities. Dr. Holterman continues to perform surgery on children to correct airway obstructions, lung problems and abdominal disorders.
*Additional training & Certifications:
After completing his fellowship at the University of Washington, Dr. Holterman was accepted into a research study program in Montreal. Dr. Holterman spent 24 months as a research associate at the Clinical Research Institute in Montreal. Dr. Holterman is a highly respected Physician and Pediatric Surgeon. It appears that Dr. Mark Holterman is very much in demand within the Chicago area.
Dr. Mark Homterman is currently Board Certified in Pediatric Medicine and Surgery. In addition, Dr. Holterman has a current and valid medical license.
Dr. Mark Holterman has written several research publications. In addition, he has also participated a variety of medical research studies since starting his medical career. Dr. Holterman has plans to begin lecturing as well as visiting medical research facilities throughout the United States. Visit markjholterman.strikingly.com to know more.
It was recently announced that innovative medical company Tempus has raised more than $70 million in funds. The funds came from two core investors in the series C round, New Enterprise Associates and Investors Revolution Growth. Overall, Tempus has raised more than $130 million in three separate rounds of funding. This has all been raised since the company started in just 2015, launching it from a small medical startup to a top game changer in the field of cancer diagnostics. According to a recent article in Forbes Magazine, this brings the total valuation of Tempus to about $700 million dollars.
Tempus was co-founded by Eric Lefkofsky, who is a serial entrepreneur that also founded Groupon. He currently serves as Tempus’s Chief Executive Officer. Tempus is a rapidly growing technology company that focuses on data driven cancer care. It is a complete informational system that is seeking to become the world’s largest data base of cancer information.
Lefkofsky founded Tempus after realizing that although there is a mass of data about cancer treatment and research methods there was no singular operating system that allowed doctors to access that data. Most of the information was contained in physicians notes that were filed away at individual hospitals rather than a central system. Tempus is seeking to change all that by centralizing the data and information.
Lefkofsky’s vision is to utilize the power of technology to complete this process. This is incredibly beneficial for the cancer patients who can benefit from this information being in the hands of their oncologists and the team. Cancer care becomes completely personal with access to this multitude of information. Research gained from one patient can be accessed by an oncologist on the other side of the country in real time. Additionally, Tempus is scaling its Business to Business partnership. In 2016 they have partnered with the Cleveland Clinic, the Mayo Clinic and Duke University. Tempus continues to grow and scale, with more and more partnerships in the works for 2017 and beyond.
Board Certified Plastic Surgeon Dr. Jennifer Walden recently moved her lucrative practice from the bright lights of New York to her Texas roots. Walden was recently named a Super Doctor by Texas Monthly magazine. Nominees are selected by peers and through research conducted by MSC Communications.
Walden is a member of several prestigious organizations such as the American Society of Plastic Surgeons and the American Society of Aesthetic Plastic Surgeons. She is also a highly sought-after spokesperson and an active participants on a number of boards.
Dr. Walden has a long relationship with the prestigious Manhattan Eye, Ear and Throat Clinic where she was an attending plastic surgeon. She also served as clinical instructor at the University Langone Medical Center. While in New York, Dr. Walden honed her skills under the tutelage of some of the best cosmetic surgeons in the business. She considers Dr. Sherill Alston her mentor.
Her long list of highly-satisfied clientele reads like a who’s who list throughout the nation. Dr. Walden performs a number of cosmetic procedures including breast augmentation, eyebrow lift, Botox injections and tummy tucks. Instagram Photos.
Dr. Walden says she always wanted to go into medicine. After graduating from High School, she received a bachelor’s degree in biology from the University of Texas. She continued her training at the University of Texas Medical Branch. She graduated with the highest honors and was inducted in the prestigious Texas Alpha Chapter of Alpha Omega Alpha Honor Medical Society.
After giving birth to twin boys, Dr. Walden moved back to Austin and set up a practice at the Westlake Cosmetic Surgery Center. While some people are a bit intimidated by plastic surgery, Dr. Walden insists that people should do if there is something about their appearance that they want to improve.
Learn more about her: http://www.vitals.com/doctors/Dr_Jennifer_Walden/reviews